In this webinar we discuss our 3D disease models and their use in drug development emphasizing the capacity of our patient-derived platform to mimic the native architecture of human tissues in an organ- and disease-specific manner and its high correlation with clinical response.


Predictive Oncology
Proactive interview focuses on new category of oncology drug discovery
Predictive Oncology CEO Raymond Vennare and Dr. Robert Murphy, an inventor of the engine behind our artificial intelligence (AI) platform and new member of our